Risk-based stratification of carcinomas concurrently involving the endometrium and ovary Journal Article
| Authors: | Turashvili, G.; Gómez-Hidalgo, N. R.; Flynn, J.; Gonen, M.; Leitao, M. M. Jr; Soslow, R. A.; Murali, R. |
| Article Title: | Risk-based stratification of carcinomas concurrently involving the endometrium and ovary |
| Abstract: | Objective: Determining whether carcinomas concurrently involving endometrium and ovary are independent primary tumors (IPTs) or endometrial carcinomas with ovarian metastases (at least stage IIIA endometrial cancers, IIIA-EC) using clinicopathologic criteria is often challenging. Recent genomic studies showed that most such tumors are clonally related. We sought to identify clinicopathologic features associated with clinical outcomes, and to separate women with these tumors into clinically low-risk and high-risk groups. Methods: We reviewed clinical and pathologic data from 74 women who, between 1993 and 2014, underwent primary surgery for endometrial cancer and had concurrent ovarian involvement. Results: The endometrial carcinomas were endometrioid (EECs, n = 41) or non-endometrioid (ENECs, n = 33). Nineteen (26%) cases were originally classified as IPTs using clinicopathologic criteria. Multivariate analysis revealed that lymph node involvement (hazard ratio (HR) = 2.38, 95% CI 1.13–5.02, p = 0.023) and non-endometrioid endometrial tumor histology (HR = 6.27, 95% CI 2.6–15.13, p < 0.001) were associated with poorer progression-free survival (PFS). Multivariate analysis of 65 women with known lymph node status revealed two prognostically distinct groups: a high-risk group comprising ENECs with ≥50% myometrial invasion irrespective of lymph node status (n = 21; median PFS 12.7 months, 95% CI, 9.24–19.8); and a low-risk group consisting of all EECs, as well as lymph node-negative ENECs with <50% myometrial invasion (n = 44, median PFS not reached). The risk-based classification was superior to the original classification of endometrial cancers as IPTs vs. IIIA-EC for predicting PFS (log-rank test, p < 0.001 vs. p = 0.07). Conclusion: Our proposed risk-based stratification enables categorization of women with concurrent endometrial and ovarian tumors according to their likely clinical outcomes. © 2018 Elsevier Inc. |
| Keywords: | adult; controlled study; human tissue; aged; human cell; major clinical study; clinical feature; histopathology; lymph node metastasis; endometrioid carcinoma; endometrium carcinoma; progression free survival; ovary; ovary carcinoma; high risk population; cancer classification; gynecologic surgery; endometrium; ascites fluid cytology; clinical outcome; tumor invasion; cancer prognosis; low risk population; human; female; priority journal; article; non-endometrioid carcinoma; synchronous carcinomas |
| Journal Title: | Gynecologic Oncology |
| Volume: | 152 |
| Issue: | 1 |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-01-01 |
| Start Page: | 38 |
| End Page: | 45 |
| Language: | English |
| DOI: | 10.1016/j.ygyno.2018.10.033 |
| PUBMED: | 30413340 |
| PROVIDER: | scopus |
| PMCID: | PMC6321787 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 February 2019 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work